Delivery Order #SPE2DR26F1CAJ

Delivery Order for Naloxone Nasal Spray to AmerisourceBergen

This award is a delivery order contract under a larger indefinite delivery vehicle (IDV) held by AmerisourceBergen Drug Corp, a prominent pharmaceutical sourcing and distribution company. The specific procurement involves Naloxone HCL 4 mg nasal spray, an essential medication used to counteract opioid overdoses, highlighting its critical role in public health initiatives. The work scope is focused on the supply and timely delivery of this nasal spray to support emergency medical responses, reflecting the contract's importance in addressing opioid-related health emergencies. The contract was awarded as a delivery order, indicating fulfillment under pre-existing terms of the IDV, streamlining supply without a separate competitive bid for this order. The timeline for performance is brief, covering a short period in early March 2026, ensuring rapid distribution of needed medication. This-contract-derives-from a parent indefinite delivery vehicle contract, which guarantees continuous pharmaceutical services over an extended period, underscoring its significance for sustained medical supply chains.

Description

4571004092!NALOXONE HCL 4 MG NASAL SPRAY 2S

View original record